Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

kSep Systems

2011 FOUNDED
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer of single-use, scalable bio-processing and centrifugal systems designed to provide bio-pharmaceutical contract development and manufacturing services. The company's bio-processing services include fully automated centrifugal systems used for manufacturing vaccines, cell-based therapeutics and monoclonal antibodies, enabling bio-pharmaceutical companies to solve the problems of traditional centrifugation based systems for clients in the areas of recombinant therapeutics, cell therapy, and vaccines manufacturing by providing a gentle processing environment for the concentration, washing, and separation of cells while maintaining high recoveries.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Technology Systems
Other Industries
Electronic Equipment and Instruments
Primary Office
  • 598 Airport Boulevard
  • Suite 600
  • Morrisville, NC 27560
  • United States

kSep Systems Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore kSep Systems‘s full profile, request access.

Request full access to PitchBook

kSep Systems Executive Team (2)

Name Title Board
Seat
Contact
Info
Sunil Mehta Ph.D Co-Founder, President & Chief Executive Officer
Ann Miller Controller